Biomerica, Inc. (BMRA )

Currency in USD Disclaimer
$0.56 -$0.05 (-7.68%)
Open 03/13/2025
$0.55
$0.62
$0.24
$1.27

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol BMRA
  • Company Biomerica, Inc.
  • Price $0.56
  • Changes Percentage -7.68
  • Change -0.0464
  • Day Low $0.55
  • Day High $0.62
  • Year High $1.27
  • Year Low $0.24
  • Market Cap $10,347,569
  • Price Avg 50 EMA (D) $0.59
  • Price Avg 200 EMA (D) $0.43
  • Exchange NASDAQ
  • Volume 136,762
  • Average Volume 7,933,848
  • Open $0.6
  • Previous Close $0.6
  • EPS -0.33
  • PE -1.71
  • Earnings Announcement 2025-04-10 10:59:00
  • Shares Outstanding $18,337,000

Company brief: BIOMERICA, INC. (BMRA )

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

BMRA Corporation News

Income Statement